Healing & Regeneration Peptides
Research peptides for tissue repair, wound healing and systemic regeneration processes. At the centre stand BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4), the two most-cited compounds in preclinical models of tendon, muscle and gastric barrier repair, alongside the popular Wolverine stack combining both. In addition, the copper tripeptide GHK-Cu for skin regeneration models and KPV as a short tripeptide fragment of Alpha-MSH. All peptides ship with a batch-specific Janoshik third-party CoA on the product page.
All products
Related research
August 5, 2026
Do BPC-157 and TB-500 Promote Tumors? What the Angiogenesis Research Shows
BPC-157 and TB-500 promote angiogenesis, and tumors need blood vessels. An honest look at the evidence, the TB-500 distinction, and the question never asked.
Read more →
July 31, 2026
BPC-157 and TB-500 in Serum: What a New Anti-Doping Lab Study Measures About Degradation
A July 2026 analytical study reports complete degradation of BPC-157 and TB-500 only in serum. What the numbers say, and what they explicitly do not say.
Read more →
July 24, 2026
The FDA's July 2026 Peptide Vote: What It Means for BPC-157, TB-500 and KPV
On 23-24 July 2026 an FDA advisory panel voted 8-6 to recommend BPC-157, KPV and TB-500 for the US compounding list, against the agency's own scientists. What that vote is, and what it is not.
Read more →
